NICE gateway - current consultations and topics in development

This page guides you to the various sections of the NICE website which have details about the guidelines and the different kinds of guidance in development. It also highlights new topics which have been selected for guideline and guidance development.

Please email Caroline Rapu (caroline.rapu@rcn.org.uk), RCN Project Manager, if you would like to be involved in any of the topics on behalf of the RCN.

For further details of how you can contribute to this work see Getting involved.

Relevant pages on the NICE website

Current NICE consultations

There are consultations at different stages in the development of guidelines and guidance. This page on the NICE website lists the consultations which are currently in progress showing topic, type of guidance and consultation stage - go to Current NICE consultations.

Guidance in development

This section of the NICE website links to lists of all guidelines and guidance in development arranged by the different types. The lists within each type are arranged in alphabetical order of topic and the number of topics are indicated. You can use the Show All button to see the whole list on one page - go to Guidance in development.

New topics

New topics for guideline and guidance development are listed below on a monthly basis. We will keep a three monthly listing here with the most recent listed first. For guidelines and guidance in development prior to this see the section above.

The RCN is seeking nurses/midwives with expertise and knowledge of the following areas to participate in the listed topics. If you are interested in any of these topics, or in any of the topics listed on the NICE website, please email Caroline Rapu (caroline.rapu@rcn.org.uk), RCN Project Manager.

April 2013 - NICE guidelines, public health guidance and quality standards

Asthma – diagnosis and monitoring: guideline scope
Autism – management of autism in children and young people: draft guideline
Acute kidney injury: draft guideline
Delaying the onset of disability, frailty and dementia in later life: scope consultation
Depression in children and young people: quality standard
Multiple Pregnancy: quality standard
Patient Group Directions: draft good practice guidance
Smoking cessation - acute, maternity and mental health services: draft public health guidance

March 2013 - NICE guidelines, public health guidance and quality standards

Autism: quality standard
Familial hypercholesterolaemia: quality Standard
Smoking Cessation – supporting people to stop smoking: quality standard
Atopic eczema: quality standard
Headaches: quality standard
Joint Trauma - Complex Fractures: scope consultation
Joint Trauma - Non - Complex Fractures: scope consultation
Joint Trauma - Major Trauma: scope consultation
Joint Trauma - Spinal Injury Assessment: scope consultation
Acute Kidney Injury: guideline consultation
Anaemia in chronic kidney disease: guideline
Coeliac disease: guideline
Faecal incontinence: quality standard
Mental well being of older people in residential care homes: quality standard
Spinal cord compression: quality standard
Varicose veins: guideline consultation
Vitamin D deficiency: guideline

April 2013 - NICE technology appraisals and medical technologies

Eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura (review of TA205): appraisal consultation
Erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer-treatment induced anaemia
Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel – diagnostic procedure
Lung cancer (non-small-cell, anaplastic lymphoma kinase fusion gene, previously treated) - crizotinib: appraisal consultation
Pixantrone for non Hodgkin's lymphoma (relapsed refractory)
Vision Amniotic Leak Detector to assess unexplained vaginal wetness in pregnancy: medical technology consultation
Lung cancer - Review of NICE Technology Appraisal Guidance No.192; Gefitinib for the treatment of non-small cell lung cancer (first line), No.227; Erlotinib monotherapy for the maintenance treatment of advanced or metastatic non-small cell lung cancer, and No.258; Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer
Stroke - Review of NICE Technology Appraisal Guidance No.249; Dabigatran etexilate for the prevention of stroke in atrial fibrillation, No. 256; Rivaroxaban for the prevention of stroke in atrial fibrillation, and No. 275; Apixaban for the prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation with one or more risk factor for stroke or systemic embolism